Skip to search boxSkip to navigationSkip to main content

Time to response and survival in hypomethylating agent-treated acute myeloid leukemia

  • Prajwal Boddu
    ,
  • Hagop Kantarjian
    ,
  • Guillermo Garcia-Manero
    ,
  • Farhad Ravandi
    ,
  • Elias Jabbour
    ,
  • Gautam Borthakur
*Corresponding author for this work
  • University of Texas Health Science Center at Houston
Scholary Output:
Contribution to journal
Letter
 Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Letter
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1012-1015 (4 pages)

Journal (Volume, Issue Number)

Leukemia and Lymphoma (Volume 59, Issue 4)

Publication milestones

  • Published - 08/23/2018

Publication status

Published - 08/23/2018

ISSN

1042-8194

Publication IDs

  • Scopus: 85028573270
  • PubMed: 28838278
  • ORCID: /0000-0002-8636-1071/work/68888076

Access to documents

Publication metrics

Metrics

Scopus
citations
3, opens in new tab
SciVal
FWCI
0.60
SciVal
Author count
11
SciVal
citations
2
SciVal
Paper percentile
49
Fractional count
1
Fractional count
0.09
Fractional count
10
Fractional count
0.91
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
7
Citation count
3

Funding Details

Our funding was from the following sources – Supported in part by the MD Anderson Cancer Center Support Grant CA016672 (PI: Dr. Ronald DePinho) and Award Number P01 CA049639.
FundersFunding numbers
NCI
P30CA016672
MD Anderson Cancer Center
P01 CA049639, CA016672